-+ 0.00%
-+ 0.00%
-+ 0.00%

ADIAL PHARMACEUTICALS EXPANDS INTELLECTUAL PROPERTY PORTFOLIO WITH NEW U.S. PATENT GRANTED FOR GENETIC-BASED TREATMENT OF ALCOHOL AND OPIOID USE DISORDERS

Reuters·05/01/2025 12:30:00

Please log in to view news